Literature DB >> 16822801

Beneficial effect of combined aspiration and interstitial laser therapy in patients with benign cystic thyroid nodules: a pilot study.

H Døssing1, F N Bennedbaek, L Hegedüs.   

Abstract

The aim of this study was to evaluate the effect of combined cyst aspiration and ultrasound-guided interstitial laser photocoagulation (ILP) on recurrence rate and the volume of benign cystic thyroid nodules. 10 euthyroid outpatients with a solitary and cytologically benign partially cystic thyroid nodule causing local discomfort were assigned to cyst aspiration followed by ultrasound-guided ILP and followed for 12 months. The ILP was performed under continuous ultrasound-guidance and with an output power of 2.5-3.5 W. The volume of the nodules was assessed by means of ultrasound and determination of the amount of aspirated cyst fluid, thereby calculating the volume of the solid part. Follow-up included ultrasound and determination of thyroid function. Pressure and cosmetic complaints were evaluated on a visual analogue scale. The median initial volume of the cystic nodule decreased from 9.6 ml [6.8;15.5 (quartiles)] to 3.5 ml [2.7;9.0 (quartiles)] (p = 0.0001), and the median cyst volume from 3.0 ml [2.0;6.0 (quartiles)] to 0 ml [0;0.5 (quartiles)] (p = 0.0001) during follow-up. Recurrence of the cystic part was defined as a cyst volume > 1 ml. In eight of 10 patients there was no recurrence of the cystic part. Both pressure symptoms and cosmetic complaints were significantly reduced. The only side effect was mild pain or tenderness for a few days. Our study suggests that complete cyst aspiration and subsequent ultrasound-guided ILP of benign cystic thyroid nodules is a feasible and safe technique, resulting in a significant reduction in the volume of both the solid and the cystic component. A large-scale prospective randomized study is warranted.

Entities:  

Mesh:

Year:  2006        PMID: 16822801     DOI: 10.1259/bjr/40698061

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  7 in total

1.  Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules.

Authors:  Jung Hwan Baek; Won-Jin Moon; Yoon Suk Kim; Jeong Hyun Lee; Ducky Lee
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

2.  Combination therapy consisting of ethanol and radiofrequency ablation for predominantly cystic thyroid nodules.

Authors:  H M Yoon; J H Baek; J H Lee; E J Ha; J K Kim; J H Yoon; W B Kim
Journal:  AJNR Am J Neuroradiol       Date:  2013-08-22       Impact factor: 3.825

Review 3.  Thermal ablation for benign thyroid nodules: radiofrequency and laser.

Authors:  Jung Hwan Baek; Jeong Hyun Lee; Roberto Valcavi; Claudio M Pacella; Hyunchul Rhim; Dong Gyu Na
Journal:  Korean J Radiol       Date:  2011-08-24       Impact factor: 3.500

Review 4.  Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations.

Authors:  Dong Gyu Na; Jeong Hyun Lee; So Lyung Jung; Ji-Hoon Kim; Jin Yong Sung; Jung Hee Shin; Eun-Kyung Kim; Joon Hyung Lee; Dong Wook Kim; Jeong Seon Park; Kyu Sun Kim; Seon Mi Baek; Younghen Lee; Semin Chong; Jung Suk Sim; Jung Yin Huh; Jae-Ik Bae; Kyung Tae Kim; Song Yee Han; Min Young Bae; Yoon Suk Kim; Jung Hwan Baek
Journal:  Korean J Radiol       Date:  2012-03-07       Impact factor: 3.500

Review 5.  Innovative Techniques for Image-Guided Ablation of Benign Thyroid Nodules: Combined Ethanol and Radiofrequency Ablation.

Authors:  Hye Sun Park; Jung Hwan Baek; Young Jun Choi; Jeong Hyun Lee
Journal:  Korean J Radiol       Date:  2017-04-03       Impact factor: 3.500

6.  Unfavorable Outcomes in Solid and Spongiform Thyroid Nodules Treated with Laser Ablation. A 5-Year Follow-up Retrospective Study.

Authors:  Roberto Negro; Gabriele Greco
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2019       Impact factor: 2.895

7.  Long-term outcome following laser therapy of benign cystic-solid thyroid nodules.

Authors:  Helle Døssing; Finn Noe Bennedbæk; Laszlo Hegedüs
Journal:  Endocr Connect       Date:  2019-07       Impact factor: 3.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.